Cargando…
Manufacturing human mesenchymal stem cells at clinical scale: process and regulatory challenges
Human mesenchymal stem cell (hMSC)-based therapies are of increasing interest in the field of regenerative medicine. As economic considerations have shown, allogeneic therapy seems to be the most cost-effective method. Standardized procedures based on instrumented single-use bioreactors have been sh...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5895685/ https://www.ncbi.nlm.nih.gov/pubmed/29564526 http://dx.doi.org/10.1007/s00253-018-8912-x |